Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase 2 7Phase 2/3 3Phase 4 2Phase 1 2Phase NA 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Fatigue 2Prostatic Neoplasms 1Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Methylphenidate × Clear all
NCT03772834 2026-05-04

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT00424099 2023-06-01

Methylphenidate and a Nursing Telephone Intervention for Fatigue

M.D. Anderson Cancer Center

Phase 2/3 Completed
197 enrolled 10 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡